FindTrial
Sign In

Human Papillomavirus Vaccine

BIOLOGICAL5 trials

Sponsors

Indiana University, University of Missouri-Columbia, Mayo Clinic, University of Witwatersrand, South Africa, Dalhousie University

Conditions

Cervical High Grade Squamous Intraepithelial LesionChronic Kidney DiseaseDialysisHealthyInflammatory Bowel DiseaseRecurrent Respiratory PapillomatosisUterine Cervical Dysplasia

Early Phase 1

Therapeutic Treatment With Human Papillomavirus Quadrivalent Vaccine for Recurrent Respiratory Papillomatosis
WithdrawnNCT00829608
University of Missouri-ColumbiaRecurrent Respiratory Papillomatosis
Start: 2009-01-31End: 2010-06-30Updated: 2016-10-05

Phase 1

A Controlled Study to Evaluate the Safety and Immunogenicity of StreptAnova™ in Healthy Adults
NCT02564237
Dalhousie UniversityHealthy
Start: 2015-08-31End: 2017-12-31Updated: 2017-01-19

Phase 2

Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL
CompletedNCT01928225
University of Witwatersrand, South AfricaCervical High Grade Squamous Intraepithelial Lesion
Start: 2014-09-02End: 2018-03-01Updated: 2020-06-24

Phase 4

Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease
CompletedNCT01034358
Mayo ClinicInflammatory Bowel Disease, Uterine Cervical Dysplasia
Start: 2010-02-28End: 2011-06-30Updated: 2012-10-23

Unknown Phase

The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients
CompletedNCT00767897
Indiana UniversityChronic Kidney Disease, Dialysis
Start: 2011-11-30End: 2018-12-31Updated: 2024-03-29

Related Papers

Immunogenicity of a 30-valent M protein mRNA group A Streptococcus vaccine.
2024-08-137 citations
Human Papillomavirus Vaccination Prior to Loop Electroexcision Procedure Does Not Prevent Recurrent Cervical High-grade Squamous Intraepithelial Lesions in Women Living With Human Immunodeficiency Virus: A Randomized, Double-blind, Placebo-controlled Trial
Clinical Infectious Diseases2020-09-2324 citations
Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I study.
2019-12-1375 citations
Effect of Human Papillomavirus Vaccine to Interrupt Recurrence of Vulvar and Anal Neoplasia (VIVA)
JAMA Network Open2019-04-1230 citations
Results disclosure of papilloma vaccine studies in humans completed before January 1st, 2011.
Figshare2014-01-01
Results disclosure of papilloma vaccine studies in humans co.
Figshare2014-01-01